Legal & General Group
OMGA

Legal & General Group’s Omega Therapeutics, Inc. Common Stock OMGA Stock Holding History

Legal & General Group’s Portfolio OMGA Stock Details OMGA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-2,971
Closed -$10.8K – 3534
2024
Q1 		$10.8K Hold
2,971
– – ﹤0.01% 3187
2023
Q4 		$8.94K Hold
2,971
– – ﹤0.01% 3256
2023
Q3 		$6.46K Hold
2,971
– – ﹤0.01% 3339
2023
Q2 		$16.6K Buy
+2,971
New +$23.2K ﹤0.01% 3186
2022
Q2 		– Sell
-2,156
Closed -$13K – 3687
2022
Q1 		$13K Buy
2,156
+1,433
+198% +$14.6K ﹤0.01% 3346
2021
Q4 		$8K Hold
723
– – ﹤0.01% 3502
2021
Q3 		$14K Buy
+723
New +$13.9K ﹤0.01% 3385

Other funds holding OMGA

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $101M AUM 38.13% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Legal & General Group's OMGA Position: Q2 2024 in Review

Legal & General Group sold out of Omega Therapeutics, Inc. Common Stock (OMGA) in Q2 2024, closing a stake of 2,971 shares — an estimated $10.8K sold.

Legal & General Group first reported a position in OMGA in Q3 2021 and held it in 7 quarters. The position peaked at $16.6K in Q2 2023. 68 funds tracked by Wall St. Rank hold OMGA as of Q2 2024.

  • Legal & General Group reported no remaining Omega Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Legal & General Group sold 2,971 Omega Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $10.8K.
  • Legal & General Group first reported a position in Omega Therapeutics, Inc. Common Stock in Q3 2021 and held it in 7 quarters.
  • Legal & General Group's Omega Therapeutics, Inc. Common Stock position peaked at $16.6K in Q2 2023.
  • 68 funds tracked by Wall St. Rank held Omega Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Legal & General Group's 13F filing for Q2 2024, filed 14 Aug 2024.